Not Even Close

Médecins Sans Frontières Access Campaign

20 pp. 972 kB

This issue brief provides information on currently available hepatitis C virus (HCV) diagnostics and treatments, including pricing and registration information from manufacturers of direct-acting antivirals (DAAs). Reasons underlying the continued lack of access to HCV treatment are discussed, including delayed scale-up by governments, intellectual property barriers, regulatory challenges and high prices.

(Visited 24 times, 1 visits today)
This entry was posted in Essential Medicines, General, Other Infectious Diseases. Bookmark the permalink.